Pharvaris NV (PHVS) is around the top of the Biotechnology industry according to InvestorsObserver. PHVS received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. Pharvaris NV also achieved a score of 83 in the Biotechnology industry, putting it above 83 percent of Biotechnology stocks. Biotechnology is ranked 57 out of the 148 industries.
PHVS has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on PHVS!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Pharvaris NV Stock Today?
Pharvaris NV (PHVS) stock has risen 11.34% while the S&P 500 is lower by -0.74% as of 11:47 AM on Wednesday, Dec 28. PHVS is higher by $1.14 from the previous closing price of $10.05 on volume of 244,988 shares. Over the past year the S&P 500 is lower by -20.59% while PHVS is lower by -27.34%. PHVS lost -$1.77 per share the over the last 12 months.
Click Here to get the full Stock Report for Pharvaris NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
